Clorox (CLX) Misses Q3 EPS by 2c, Raises Low End of FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
The Clorox Company Reports 3 Percent Sales Growth in Q3; Updates Fiscal Year 2015 Outlook for Sales and EPS
May 1, 2015 8:30 AM EDTOAKLAND, CA -- (Marketwired) -- 05/01/15 -- The Clorox Company (NYSE: CLX) today reported sales growth of 3 percent and a decrease of 5 percent diluted net earnings per share (EPS) from continuing operations for its third quarter, which ended March 31, 2015. On a currency-neutral basis, sales grew 5 percent.
"I'm pleased we delivered strong results in the third quarter, allowing us to raise our fiscal year sales outlook and update our EPS outlook," said Chief Executive Officer Benno Dorer. "All U.S. segments contributed to sales growth, and sales for International grew strongly on a currency-neutral basis. Importantly,... More
